Purpose: The purpose of the study was to evaluate the knowledge level of the Chat Generative Pretrained Transformer (ChatGPT), Bard, and Bing artificial intelligence (AI) chatbots regarding ocular inflammation, uveal diseases, and treatment modalities, and to investigate their relative performance compared to one another.

Materials And Methods: Thirty-six questions related to ocular inflammation, uveal diseases, and treatment modalities were posed to the ChatGPT, Bard, and Bing AI chatbots, and both correct and incorrect responses were recorded. The accuracy rates were compared using the Chi-squared test.

Results: The ChatGPT provided correct answers to 52.8% of the questions, while Bard answered 38.9% correctly, and Bing answered 44.4% correctly. All three AI programs provided identical responses to 20 (55.6%) of the questions, with 45% of these responses being correct and 55% incorrect. No significant difference was observed between the correct and incorrect responses from the three AI chatbots ( = 0.654).

Conclusion: AI chatbots should be developed to provide widespread access to accurate information about ocular inflammation, uveal diseases, and treatment modalities. Future research could explore ways to enhance the performance of these chatbots.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11488809PMC
http://dx.doi.org/10.4103/tjo.TJO-D-23-00166DOI Listing

Publication Analysis

Top Keywords

ocular inflammation
16
diseases treatment
16
treatment modalities
16
inflammation uveal
12
uveal diseases
12
artificial intelligence
8
chatgpt bard
8
bard bing
8
correct incorrect
8
incorrect responses
8

Similar Publications

Purpose: To describe a rare case of infectious keratitis secondary to Brevundimonas diminuta, a gram-negative bacillus with fluoroquinolone resistance and rare clinical isolation.

Methods: A 50-year-old man with contact lens overuse presented with a large corneal ulcer and hand motion visual acuity. Initial treatment with fortified topical tobramycin and vancomycin yielded slow improvement, and initial culture grew Staphylococcus epidermidis, Staphylococcus hominis, and Corynebacterium bovis.

View Article and Find Full Text PDF

Conventional treatments for autoimmune uveitis, such as corticosteroids and systemic immunosuppressants, often result in adverse side effects, prompting the need for therapies targeting specific molecular pathways. This study investigates the effects of Arctiin, known for its diverse biological properties, on experimental autoimmune uveitis (EAU) through its action on Th17 cells and the JAK/STAT signaling pathway. Our findings reveal that Arctiin significantly alleviates EAU by reducing clinical scores, inflammatory cell infiltration, and levels of inflammatory cytokines like IL-17 and TNF-α in the eye.

View Article and Find Full Text PDF

COVID-19, caused by SARS-CoV-2, has presented formidable challenges to global health since its emergence in late 2019. While primarily known for respiratory symptoms, it can also affect the ocular surface. This review summarizes the effects of SARS-CoV-2 on ocular surface immunity and inflammation, focusing on infection mechanisms, immune responses, and clinical manifestations.

View Article and Find Full Text PDF

The widespread use of light-emitting diodes (LEDs) has increased blue light (BL) exposure, raising concerns about its potential adverse effects on ocular health. Prolonged exposure to BL has been implicated in the pathogenesis of various retinal disorders, including age-related macular degeneration (AMD), primarily through mechanisms involving oxidative stress and inflammation mediated by the overproduction of reactive oxygen species (ROS). This review synthesizes current evidence on the photoprotective properties of dietary bioactive compounds, (e.

View Article and Find Full Text PDF

: This study aimed to evaluate the therapeutic effects of combined 5% lifitegrast (LF) and tocopherol (TCP) eye drops in a murine experimental dry eye (EDE) model. Female C57BL/6 were divided into seven groups: untreated controls, EDE control, EDE + 0.05% cyclosporin A (CsA), EDE + tocopherol (TCP), EDE + 5% LF, EDE + 5% LF + TCP (once daily), and EDE + 5% LF + TCP (twice daily).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!